PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Butanol fractions of leaves reduced blood glucose levels, improved glucose tolerance, increased serum insulin levels and sensitivity, and protected pancreatic β-cells in diabetic rats [PMID:33370536, PMID:34763044].
Bark methanolic extract (BfME) at 400 and 800 mg/kg delayed the onset of diarrhea in mice models [PMID:34727589].
Extracts demonstrated antischistosomal activity against newly transformed schistosomula and adult Schistosoma mansoni in vitro [PMID:39281066].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36082325 (2022) — Bridelia ferruginea Benth.; An ethnomedicinal, phytochemical, pharmacological and toxicological review. · Heliyon
- 2.PMID: 33272106 (2022) — In vitro and computational studies of the antioxidant and anti-diabetic properties of Bridelia ferruginea. · Journal of biomolecular structure & dynamics
- 3.PMID: 34763044 (2022) — Bridelia ferruginea Benth. (Euphorbiaceae) mitigates oxidative imbalance and lipotoxicity, with concomitant modulation of insulin signaling pathways via GLUT4 upregulation in hepatic tissues of diabetic rats. · Journal of ethnopharmacology
- 4.PMID: 39281066 (2024) — In Vitro Antischistosomal Activity of Bridelia ferruginea, Clausena anisata, Khaya senegalensis, and Vernonia amygdalina. · Journal of tropical medicine
- 5.PMID: 34727589